A meta‐analysis of randomized controlled studies examining the effects of sodium‐glucose co‐transporter‐2 inhibitors on peripheral artery disease and risk of amputations

Documenti analoghi

• The effect of sodium‐glucose cotransporter‐2 inhibitors on inflammatory biomarkers: A meta‐analysis of randomized controlled trials
  di: Leonardo Buttice, et al.
  Pubblicazione: (2024)
• A review of the safety of sodium‐glucose co‐transporter‐2 inhibitors
  di: Daniel Vincent O'Hara, et al.
  Pubblicazione: (2025)
• Superior benefits of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease: A cohort study
  di: Hsiao‐Ling Chen, et al.
  Pubblicazione: (2024)
• Slowing the progression of diabetic and non‐diabetic kidney disease: A summary of the current evidence base for sodium‐glucose co‐transporter‐2 inhibitors
  di: Viktor Rotbain Curovic, et al.
  Pubblicazione: (2024)
• Individual treatment effects of sodium‐glucose co‐transporter‐2 inhibitors on the risk of chronic kidney disease in patients with type 2 diabetes: A counterfactual prediction model based on real‐world data
  di: Sukanya Siriyotha, et al.
  Pubblicazione: (2024)